The anti-tumor drug bleomycin preferentially cleaves at the transcription start sites of actively transcribed genes in human cells

Title
The anti-tumor drug bleomycin preferentially cleaves at the transcription start sites of actively transcribed genes in human cells
Authors
Keywords
Anti-tumor agent, Bleomycin, Chromatin, DNA damage, Next-generation sequencing
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 71, Issue 8, Pages 1505-1512
Publisher
Springer Nature
Online
2013-08-28
DOI
10.1007/s00018-013-1456-4

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More